Provided by Tiger Fintech (Singapore) Pte. Ltd.

bioAffinity Technologies, Inc.

0.2922
+0.00020.07%
Volume:126.31K
Turnover:37.94K
Market Cap:4.55M
PE:-0.37
High:0.3200
Open:0.2960
Low:0.2840
Close:0.2920
Loading ...

bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic

Business Wire
·
22 Jan

bioAffinity Technologies Boosts Sales with CyPath Lung

TipRanks
·
21 Dec 2024

bioAffinity Technologies Reports $2.4M Revenue For Q3 2024; Expanded CyPath Lung Test Sales To Physicians In Illinois, Alabama, And Louisiana; Now Receiving Orders From Physicians In 11 States

Benzinga
·
14 Nov 2024

bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024

THOMSON REUTERS
·
14 Nov 2024

bioAffinity Technologies Inc Qtrly EPS $-0.16

THOMSON REUTERS
·
14 Nov 2024

Press Release: bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024

Dow Jones
·
14 Nov 2024

BRIEF-BioAffinity Technologies Appoints New Chief Science Officer To Spearhead Product Development

Reuters
·
04 Nov 2024

BioAffinity Technologies appoints William Bauta, Ph.D. Chief Science Officer

TIPRANKS
·
04 Nov 2024

bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development

THOMSON REUTERS
·
04 Nov 2024

bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development

Business Wire
·
04 Nov 2024

bioAffinity Technologies Secures Japanese Patent for Lung Cancer Diagnostic Method

MT Newswires Live
·
30 Oct 2024

bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung

Business Wire
·
30 Oct 2024

BioAffinity Technologies announces closing of $2.6M registered direct offering

TIPRANKS
·
22 Oct 2024

Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement

THOMSON REUTERS
·
21 Oct 2024

WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement

PR Newswire
·
21 Oct 2024

bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement

THOMSON REUTERS
·
21 Oct 2024